| The urokinase plasminogen activator system: a target for anti-cancer therapy S Ulisse, E Baldini, S Sorrenti, M D'Armiento Current cancer drug targets 9 (1), 32-71, 2009 | 418 | 2009 |
| Q-elastosonography of solid thyroid nodules: assessment of diagnostic efficacy and interobserver variability in a large patient cohort V Cantisani, H Grazhdani, P Ricci, K Mortele, M Di Segni, V D’Andrea, ... European Radiology 24, 143-150, 2014 | 91 | 2014 |
| Q-elastography in the presurgical diagnosis of thyroid nodules with indeterminate cytology V Cantisani, S Ulisse, E Guaitoli, C De Vito, R Caruso, R Mocini, ... PLoS One 7 (11), e50725, 2012 | 87 | 2012 |
| Prognostic significance of the age factor in the thyroid cancer: statistical analysis L Falvo, A Catania, S Sorrenti, V D'Andrea, A Berni, MD Stefano, ... Journal of surgical oncology 88 (4), 217-222, 2004 | 73 | 2004 |
| Papillary thyroid cancer prognosis: An evolving field S Ulisse, E Baldini, A Lauro, D Pironi, D Tripodi, E Lori, IC Ferent, ... Cancers 13 (21), 5567, 2021 | 68 | 2021 |
| High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma S Ulisse, E Baldini, S Sorrenti, S Barollo, L Gnessi, A Catania, ... The Journal of Clinical Endocrinology & Metabolism 96 (2), 504-508, 2011 | 67 | 2011 |
| Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology? E Baldini, S Sorrenti, C Di Gioia, C De Vito, A Antonelli, L Gnessi, ... BMC Clinical Pathology 13, 1-8, 2013 | 63 | 2013 |
| Vitiligo and autoimmune thyroid disorders E Baldini, T Odorisio, S Sorrenti, A Catania, F Tartaglia, G Carbotta, ... Frontiers in endocrinology 8, 296487, 2017 | 62 | 2017 |
| Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm S Sorrenti, P Trimboli, A Catania, S Ulisse, E De Antoni, M D'Armiento Thyroid 19 (4), 355-360, 2009 | 62 | 2009 |
| Iodine: Its role in thyroid hormone biosynthesis and beyond S Sorrenti, E Baldini, D Pironi, A Lauro, V D’Orazi, F Tartaglia, D Tripodi, ... Nutrients 13 (12), 4469, 2021 | 61 | 2021 |
| Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients N Prinzi, E Baldini, S Sorrenti, C De Vito, C Tuccilli, A Catania, S Carbotta, ... Breast cancer research and treatment 144, 683-688, 2014 | 61 | 2014 |
| Thyroid imaging reporting and data system score combined with the new Italian classification for thyroid cytology improves the clinical management of indeterminate nodules S Ulisse, D Bosco, F Nardi, A Nesca, E D’Armiento, V Guglielmino, ... International journal of endocrinology 2017, 2017 | 54 | 2017 |
| Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype L Falvo, C D'Ercole, S Sorrenti, V D'Andrea, A Catania, A Berni, P Grilli, ... The European journal of surgery. Supplement.:= Acta chirurgica. Supplement …, 2003 | 54 | 2003 |
| Internet‐based versus traditional teaching and learning methods S Guarino, E Leopardi, S Sorrenti, E De Antoni, A Catania, S Alagaratnam The clinical teacher 11 (6), 449-453, 2014 | 52 | 2014 |
| In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator
and its cognate receptor, but not with … S Ulisse, E Baldini, S Sorrenti, S Barollo, N Prinzi, A Catania, A Nesca, ... Clinical endocrinology 77 (5), 780-786, 2012 | 52 | 2012 |
| Deregulation of Aurora kinase gene expression in human testicular germ cell tumours E Baldini, Y Arlot‐Bonnemains, M Mottolese, S Sentinelli, B Antoniani, ... Andrologia 42 (4), 260-267, 2010 | 52 | 2010 |
| Thyroid nodule characterization: How to assess the malignancy risk. update of the literature D Fresilli, E David, P Pacini, G Del Gaudio, V Dolcetti, GT Lucarelli, ... Diagnostics 11 (8), 1374, 2021 | 49 | 2021 |
| Artificial intelligence for thyroid nodule characterization: where are we standing? S Sorrenti, V Dolcetti, M Radzina, MI Bellini, F Frezza, K Munir, G Grani, ... Cancers 14 (14), 3357, 2022 | 47 | 2022 |
| Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment M Radzina, V Cantisani, M Rauda, MB Nielsen, C Ewertsen, ... International journal of surgery 41, S82-S93, 2017 | 47 | 2017 |
| Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm P Trimboli, E Condorelli, A Catania, S Sorrenti Diagnostic cytopathology 37 (10), 783-785, 2009 | 47 | 2009 |
